- Home
- DDL vs GHRS Comparison
DDL vs GHRS Comparison
Compare DDL & GHRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DDL
- GHRS
- Stock Information
- Founded
- DDL 2014
- GHRS 2018
- Country
- DDL China
- GHRS Ireland
- Employees
- DDL N/A
- GHRS N/A
- Industry
- DDL Catalog/Specialty Distribution
- GHRS Biotechnology: Pharmaceutical Preparations
- Sector
- DDL Consumer Discretionary
- GHRS Health Care
- Exchange
- DDL Nasdaq
- GHRS Nasdaq
- Market Cap
- DDL 731.2M
- GHRS 868.7M
- IPO Year
- DDL 2021
- GHRS 2021
- Fundamental
- Price
- DDL $3.70
- GHRS $12.51
- Analyst Decision
- DDL Sell
- GHRS Strong Buy
- Analyst Count
- DDL 1
- GHRS 3
- Target Price
- DDL $1.15
- GHRS $35.67
- AVG Volume (30 Days)
- DDL 507.8K
- GHRS 1.1M
- Earning Date
- DDL 03-03-2025
- GHRS 03-07-2025
- Dividend Yield
- DDL N/A
- GHRS N/A
- EPS Growth
- DDL N/A
- GHRS N/A
- EPS
- DDL 0.13
- GHRS N/A
- Revenue
- DDL $3,158,412,712.00
- GHRS N/A
- Revenue This Year
- DDL $17.81
- GHRS N/A
- Revenue Next Year
- DDL $16.81
- GHRS N/A
- P/E Ratio
- DDL $28.42
- GHRS N/A
- Revenue Growth
- DDL 4.61
- GHRS N/A
- 52 Week Low
- DDL $1.08
- GHRS $6.00
- 52 Week High
- DDL $4.79
- GHRS $20.50
- Technical
- Relative Strength Index (RSI)
- DDL 62.25
- GHRS 51.44
- Support Level
- DDL $3.30
- GHRS $13.50
- Resistance Level
- DDL $3.60
- GHRS $14.91
- Average True Range (ATR)
- DDL 0.16
- GHRS 1.58
- MACD
- DDL 0.05
- GHRS -0.22
- Stochastic Oscillator
- DDL 77.27
- GHRS 5.56
About DDL Dingdong (Cayman) Limited (each two representing three)
Dingdong (Cayman) Ltd is the fastest growing on-demand e-commerce company in China. The company directly provides users and households with fresh produce, meat and seafood, and other daily necessities through a convenient shopping experience supported by an extensive self-operated frontline fulfillment grid. It recognizes revenues from product sales of fresh groceries and other daily necessities through Dingdong Fresh APP and mini-programs and membership services.
About GHRS GH Research PLC
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders. The company is focused on developing novel and proprietary Mebufotenin 5-Methoxy-N, N-Dimethyltryptamine, or 5-MeO-DMT, therapies for the treatment of patients with Treatment-Resistant Depression, or TRD.